D-Arabitol
|
Basic information |
| Metabolite name | D-Arabitol |
 | HMDB0000568 |
 |
C01904 |
 |
827 |
| Synonyms | lyxitol; |
| No. of studies | 11 |
|
Basic information |
| Metabolite name | D-Arabitol |
| HMDB0000568 |
|
C01904 |
|
827 |
| Synonyms | lyxitol; |
| No. of studies | 11 |
|
Relationship between D-Arabitol and depression (count: 11) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M087 | Type2 | esketamine group 2-h vs. baseline | Plasma | Human | Down |
| Study M097 | Type1 | depressed men group vs. control men group | Urine | Human | Down |
| Study M1045 | Type1 | depression group vs. control group | Plasma | Human | Up |
| Study M1061 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M480 | Type2 | CGA-treated group vs. sleep deprivation group | Urine | Wistar rat | Down |
| Study M564 | Type1 | ACTH group vs. control group | Urine | Wistar rat | Down |
| Study M712 | Type1 | depression group vs. control group | Serum | Cynomolgus monkey | Down |
| Study M870 | Type2 | CRS + middle dose of Jia Wei Xiao Yao San group vs. CRS group | Brain | C57BL/6 mouse | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M935 | Type2 | chronic social isolation + tianeptine group vs. chronic social isolation group | Hippocampus | Wistar rat | Up |
| Study M935 | Type4 | chronic social isolation + tianeptine group vs. chronic social isolation + tianeptine resilient group | Hippocampus | Wistar rat | Up |